Davis et al. have published findings from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) demonstrating that chlorthalidone is superior to both amlodipine ...

BOSTON — The prominent headline from the highly anticipated Diuretic Comparison Project (DCP), published in late 2022, was that the antihypertensive drugs chlorthalidone and hydrochlorothiazide ...